Search Results - Ron A. A. Mathôt

Adoption of Machine Learning in Pharmacometrics: An Overview of Recent Implementations and Their Considerations by Alexander Janssen, Frank C. Bennis, Ron A. A. Mathôt

Connect to this object online.

Application of SHAP values for inferring the optimal functional form of covariates in pharmacokinetic modeling by Alexander Janssen, Mark Hoogendoorn, Marjon H. Cnossen, Ron A. A. Mathôt, the OPTI‐CLOT Study Group and SYMPHONY Consortium

Connect to this object online.

Transcapillary escape rate of 125I-albumin in relation to timing of blood sampling: the need for standardization by Youssef Chahid, Nienke M. G. Rorije, Soufian el Boujoufi, Ron A. A. Mathôt, Liffert Vogt, Hein J. Verberne

Connect to this object online.

Development and validation of an LC-MS/MS method for simultaneous quantification of co-administered trastuzumab and pertuzumab by Sandor Schokker, Fabrizia Fusetti, Francesco Bonardi, Remco J. Molenaar, Ron A.A. Mathôt, Hanneke W.M. van Laarhoven

Connect to this object online.

Deep compartment models: A deep learning approach for the reliable prediction of time‐series data in pharmacokinetic modeling by Alexander Janssen, Frank W. G. Leebeek, Marjon H. Cnossen, Ron A. A. Mathôt, the OPTI‐CLOT study group and SYMPHONY consortium

Connect to this object online.

Relationship between factor VIII levels and bleeding for rFVIII‐SingleChain in severe hemophilia A: A repeated time‐to‐event analysis by Laura H. Bukkems, Siv Jönsson, Marjon H. Cnossen, Mats O. Karlsson, Ron A. A. Mathôt, the OPTI‐CLOT studies and the SYMPHONY consortium

Connect to this object online.

PBPK modeling of recombinant factor IX Fc fusion protein (rFIXFc) and rFIX to characterize the binding to type 4 collagen in the extravascular space by Michael E. Cloesmeijer, Erik Sjögren, Sjoerd F. Koopman, Peter. J. Lenting, Marjon H. Cnossen, Ron A. A. Mathôt, the OPTI‐CLOT study group and SYMPHONY consortium

Connect to this object online.

Pharmacokinetic/Pharmacodynamic Target Attainment of Ceftazidime in Adult Patients on General Wards with Different Degrees of Renal Function: A Prospective Observational Bicenter C... by Saskia E. Zieck, Suzanne L. de Vroom, Frouke Ph. Mulder, Gitte van Twillert, Ron A. A. Mathôt, Suzanne E. Geerlings, Reinier M. van Hest

Connect to this object online.

Population Pharmacokinetics and Probability of Target Attainment of Different Dosing Regimens of Ceftazidime in Critically Ill Patients with a Proven or Suspected <i>Pseudomonas ae... by Annabel Werumeus Buning, Caspar J. Hodiamont, Natalia M. Lechner, Margriet Schokkin, Paul W. G. Elbers, Nicole P. Juffermans, Ron A. A. Mathôt, Menno D. de Jong, Reinier M. van Hest

Connect to this object online.

Systemic effects of angiogenesis inhibition alter pharmacokinetics and intratumoral delivery of nab-paclitaxel by Anne Steins, Eva A. Ebbing, Marcel C. M. Pistorius, Cynthia Waasdorp, Kausilia K. Krishnadath, Jan Paul Medema, Johanna W. Wilmink, Ron A. A. Mathôt, Maarten F. Bijlsma, Hanneke W. M. van Laarhoven

Connect to this object online.